NeuroPace Inc
For the period ended Jun 30, 2026. Filed Aug 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 11, 2026
NPCE$13.12+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets
| June 30, | December 31, | |
|---|---|---|
| (in thousands, except for share and per share amounts) | 2026 | 2025 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $12,538 | $21,692 |
| Short-term investments | 39,161 | 39,366 |
| Accounts receivable | 14,930 | 12,936 |
| Inventory | 18,111 | 14,862 |
| Prepaid expenses and other current assets | 1,453 | 1,438 |
| Current assets of discontinued operations | — | 3,779 |
| Total current assets | 86,193 | 94,073 |
| Property and equipment, net | 1,243 | 1,125 |
| Operating lease right-of-use asset | 9,216 | 10,132 |
| Restricted cash | 241 | 122 |
| Other assets | 98 | 113 |
| Total assets | $96,991 | $105,565 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $4,204 | $1,776 |
| Accrued liabilities | 10,850 | 13,184 |
| Operating lease liability | 2,256 | 2,117 |
| Deferred revenue | 123 | 141 |
| Current liabilities of discontinued operations | — | 596 |
| Total current liabilities | 17,433 | 17,814 |
| Long-term debt | 59,014 | 58,884 |
| Operating lease liability, net of current portion | 8,661 | 9,836 |
| Total liabilities | 85,108 | 86,534 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized and no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value, 200,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 34,282,567 and 33,574,759 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 34 | 34 |
| Additional paid-in capital | 577,153 | 571,412 |
| Accumulated deficit | (565,304) | (552,415) |
| Total stockholders’ equity | 11,883 | 19,031 |
| Total liabilities and stockholders’ equity | $96,991 | $105,565 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.